Investment Policy - The investment policy limits the total book value of financial investments to no more than 60% of the group's total assets, ensuring a significant portion of assets is reserved for core operational needs and liquidity [5]. - At least 30% of the investment portfolio's value must be allocated to highly liquid assets, primarily listed company stocks, to maintain financial flexibility [5]. - The group prohibits investments in high-risk or speculative products, ensuring a focus on sustainable and transparent investment opportunities [5]. Investment Strategy - The group aims for an average annualized return of approximately 15% on each investment, with a strict re-evaluation process triggered if the fair value of an investment declines by 50% from its initial cost [6]. - The investment strategy is dynamic and subject to regular review to reflect changing market conditions and regulatory requirements [7]. - The management will consider partial or full liquidation of investments to maximize shareholder value when performance targets are met or risks are managed [8]. Market Outlook - As of December 31, 2024, the group's investment portfolio is concentrated in the financial services sector, which is expected to provide attractive risk-adjusted returns and support asset diversification [8]. - The management anticipates a recovery in the financial services industry driven by improved macroeconomic conditions, increased capital market activity, and stable investor sentiment [8]. Governance and Oversight - The board retains final approval authority for major investments and regularly reviews compliance with policy limits and overall strategy [7]. - The group emphasizes a disciplined approach to capital allocation, ensuring alignment with long-term shareholder value enhancement [4].
透云生物(01332) - 2025 - 年度业绩